Countries World
The National Comprehensive Cancer Network® (NCCN®) today announced new translations of the recently-published NCCN Guidelines for Pa...
March 28, 2022 | News
i) an agreement for Innovent to obtain the sole commercialization rights to import, market, promote, distribute and detail Cyramza® (ramucirumab) ...
March 28, 2022 | News
Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization ...
March 21, 2022 | News
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
March 11, 2022 | News
CD34+ cell lots in a range of sizes also now available with high-resolution HLA information, eliminating the need for cumbersome and costly HLA screening...
March 08, 2022 | News
Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASD...
March 03, 2022 | News
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYS...
February 25, 2022 | News
Thermo Scientific SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets A new collection of caps...
February 21, 2022 | News
The Applied Biosystems SeqStudio Flex Series Genetic Analyzer delivers high-quality Sanger sequencing and fragment analysis data while providing design and...
February 10, 2022 | News
New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine ...
February 08, 2022 | News
CAS, a division of the American Chemical Society specializing in scientific information solutions, announces the launch of a major expansion of the CAS Sci...
February 02, 2022 | News
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...
February 01, 2022 | News
Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facil...
January 28, 2022 | News
The introduction of the portfolio under the Eppendorf umbrella began with the launch of the CP22N and CP30NX high-speed, floor-standing centrifuges in 2021...
January 26, 2022 | News
Most Read
Bio Jobs
News
Editor Picks